--AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement-February 2024-www.financetom.com

--AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement

May 8, 2024 11:22 AM

01:47 PM EDT, 05/08/2024 (MT Newswires) --

Price: 76.90, Change: +0.58, Percent Change: +0.76

Previous page： Looking at listing our power assets, says Gayatri Projects Next page： Expect oil demand to plateau and not peak: BP

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Looking at listing our power assets, says Gayatri Projects

Mar 19, 2018

For entire interview, watch accompanying video.

Expect oil demand to plateau and not peak: BP

Mar 13, 2018

CNBC-TV18's Anshu Sharma caught up with Spencer Dale, Group Chief Economist of BP.

MEP Infra preferred bidder for 3 NHAI projects

Mar 23, 2018

MEP Infra has emerged as the lowest bidder for 3 National Highways Authority of India (NHAI) projects. MEP in joint...

Energy Efficiency Services' arm acquires UK's Edina Power

Mar 20, 2018

Energy Efficiency Services or EESL's arm has acquired UK-based Edina Power Services. CNBC-TV18's Uttkarsh Chaturvedi caught up with Saurabh Kumar,...